Research And Development
Technology
Manufacturing

Agilent

$68.69
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.43 (-2.04%) Today
-$0.01 (-0.01%) As of 4:34 PM EDT after-hours

Why Robinhood?

You can buy or sell Agilent and other stocks, options, ETFs, and crypto commission-free!

About A

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. Read More The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that enable to identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. The Diagnostics and Genomics segment comprises activity providing active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software, and consumables. The Agilent CrossLab segment includes startup, operational, training and compliance support, software as a service, and asset management and consultative services. The company was founded in May 1999 and is headquartered in Santa Clara, CA.

Employees
14,800
Headquarters
Santa Clara, California
Founded
1999
Market Cap
21.78B
Price-Earnings Ratio
19.81
Dividend Yield
0.92
Average Volume
3.00M
High Today
$70.58
Low Today
$68.60
Open Price
$70.33
Volume
2.69M
52 Week High
$82.27
52 Week Low
$61.01

Collections

Research And Development
Technology
Manufacturing
Chemicals
Software Service
Biotechnology

A News

MarketWatchJul 11

Agilent to acquire privately held BioTek instruments for $1.165 billion

148
Yahoo FinanceJun 24

Agilent Introduces Breakthrough Flow Cytometer

237

A Earnings

$0.58
$0.66
$0.73
$0.81
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
Available Aug 14, After Hours

More A News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.